Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Q-Line Biotech Annual Report

Q-Line Biotech Limited has submitted its Annual Report for the financial year 2025-26. The full document is accessible via the provided company website link.

Source

NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Q-Line Biotech Ltd: key numbers

Share price
₹544.45
Market cap
₹1,270 Cr
Revenue (annual)
₹341.7 Cr
Net profit (annual)
₹55.72 Cr
P/E (TTM)
22.8×Sector 52.0×
Promoter holding
67.51%
FII holding
0.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Q-Line Biotech Ltd

All →
17:54 IST NSE
Partnership

Q-Line Biotech Partnership

Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.

From
Boule Medical AB
Execution
5 years

Other annual report announcements

All →